You are here

Scheduling delegate's final decisions: ACCS, November 2015

Scheduling medicines and poisons

19 November 2015

Book pagination

3 Summary

Part B - Final decisions on matters not referred to an expert advisory committee

3. Agriculture and veterinary chemicals

Summary of delegate's final decisions
Substance Final Decision
Afoxolaner and Milbemycin oxime

Schedule 5 - Amend Entries

AFOXOLANER in oral divided preparations each containing 150 mg or less of afoxolaner per dosage unit

  1. for the treatment and prevention of flea infestations and control of ticks in dogs; or
  2. for the treatment and prevention of flea infestations, control of ticks, gastrointestinal nematodes and heartworm in dogs, when combined with milbemycin oxime.

Schedule 5 - Amend Entries

MILBEMYCIN OXIME

  1. for the prophylaxis of heartworm in dogs and cats; or
  2. for the treatment and prevention of flea infestations, control of ticks, gastrointestinal nematodes and heartworm in dogs, when combined with afoxolaner, in oral divided preparations each containing 150 mg or less of afoxolaner per dosage unit.

Implementation date: 1 February 2016

BLAD (banda de Lupinus albus doce)

Appendix B - New Entry

BLAD (banda de Lupinus albus doce)

Part 1: Reasons for entry a - low toxicity

Part 2: Areas of Use 1.3 - fungicide

Implementation date: 1 February 2016

Bixafen

Schedule 5 - New Entry

BIXAFEN

Implementation date: 1 February 2016

Book pagination